Balloon Kyphoplasty in Spine Surgery Standing Out in Growth Markets

2 Min Read

Technologies in spine surgery are, for the most part, growing in sales worldwide, but some technologies are seeing rather variable growth worldwide, particularly as driven by greater adoption outside the U.S — and in particular in the Asia/Pacific region, where China is and will be contributing to increasingly larger shares of spine surgery device (and other) revenues.

Technologies in spine surgery are, for the most part, growing in sales worldwide, but some technologies are seeing rather variable growth worldwide, particularly as driven by greater adoption outside the U.S — and in particular in the Asia/Pacific region, where China is and will be contributing to increasingly larger shares of spine surgery device (and other) revenues.

To illustrate, below are the breakouts of a newer segment of the spine surgery products market — balloon kyphoplasty.  Data is illustrated on the share of worldwide sales of balloon kyphoplasty by geographic region in 2011 and 2020.  While the Americas are seeing only nominal growth (not decline) in this segment, the Asia/Pacific region is seeing dramatic growth.  Hence, by 2020, the Americas will represent a substantially smaller share of the the global market than it does in 2011.

Balloon-kyphoplasty-2011-2020

Source: “Worldwide Spine Surgery:  Products, Technologies, Markets and Opportunities 2010-2020″; Report #M520, MedMarket Diligence.

 

 

Share This Article
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Exit mobile version